Ranibizumab: Solution for intravitreal injection 1.65 mg in 0.165 mL pre-filled syringe, Solution for intravitreal injection 2.3 mg in 0.23 mL; Lucentis®
Page last updated: 29 August 2025
Page last updated: 29 August 2025
© Commonwealth of Australia
ABN: 83 605 426 759